by admin | Oct 10, 2022 | News & Opinions
by Yu-Jin Kim, Sang Ho Lee, Jisoo Im, Jihun Song, Han Young Kim & Suk Ho Bhang – Communications Biology Abstract Conditioned medium (CM) contains various therapeutic molecules produced by cells. However, the low concentration of therapeutic molecules in CM...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4VIQAQSYVZJLPBBNKLEPW3Y55I.jpg "White House unveils billion biotech spending plan ahead of industry summit")
by admin | Oct 8, 2022 | News & Opinions
By Jarrett Renshaw – Reuters The White House released new details on Wednesday on how it plans to invest more than $2 billion in the U.S. biotechnology sector as it hosts a meeting of government leaders to discuss the emerging industry. President Joe Biden on...
by admin | Oct 7, 2022 | News & Opinions
Brian Cummings, UCI professor of physical medicine & rehabilitation and founding member of the Sue & Bill Gross Stem Cell Research Center, has received a five-year, $2.7 million grant from the California Institute for Regenerative Medicine to establish a...
by admin | Sep 21, 2022 | News & Opinions
Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain by Mike Silver – TuftsNow Alzheimer’s disease can begin almost imperceptibly, often masquerading in the...
by admin | Sep 20, 2022 | News & Opinions
by Tyler Patchen and Kyle LaHucik – EndpointsNews Above image caption: Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to...
